NCT05170139

Brief Summary

To date, only one study has evaluated the effect of caffeine supplementation on athletic performance in ice hockey players finding a lack of ergogenic effect. This lack of effect is surprising as caffeine has been suggested to be an effective and safe nutritional supplement to improve physical performance in both trained and untrained individuals. Therefore, the aim of the present study is to evaluate the effect of acute caffeine ingestion (3mg/kg body mass). Thirteen elite adult ice-hockey male players will perform specific ice hockey performance tests in two separate days. On both occasions players will ingest 330 ml of water with lemon powertabs isostar® (86 kcal / 19g of carbohydrates) tablets, which will include in one of these days 3 mg/kg body mass of anhydrous caffeine. Players will perform a 35-m sprint, an agility test (Weave agility - slalom with puck), and a reaction test.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2021

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

December 9, 2021

Completed
18 days until next milestone

First Posted

Study publicly available on registry

December 27, 2021

Completed
Last Updated

May 24, 2023

Status Verified

May 1, 2023

Enrollment Period

2 months

First QC Date

December 9, 2021

Last Update Submit

May 23, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • 35m sprint time (Seconds)

    Time that participants take to skate 35 meters. Data will be collected with photoelectric cells

    One day (one hour post caffeine consumption)

  • Agility test time (Seconds)

    Time that participants take to perform an agility circuit. Data will be collected with photoelectric cells

    One day (one hour post caffeine consumption)

  • Reaction test time (seconds)

    Time that participants take to complete a reaction test circuit. Data will be collected with photoelectric cells.

    One day (one hour post caffeine consumption)

Study Arms (2)

Caffeine

EXPERIMENTAL

Dietary Supplement: Caffeine supplementation Participants will ingest caffeine in liquid form (3mg/kg) with carbohydrates.

Dietary Supplement: Caffeine

Control condition

PLACEBO COMPARATOR

Participants will ingest a drink of carbohydrates without caffeine

Dietary Supplement: Placebo drink

Interventions

CaffeineDIETARY_SUPPLEMENT

Participants will ingest a drink with 3mg/kg of body weight mixed with carbohydrates

Caffeine
Placebo drinkDIETARY_SUPPLEMENT

Participants will ingest the exact same drink without caffeine

Control condition

Eligibility Criteria

Age18 Years - 35 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Over 18 years,
  • Male
  • Play in the Spanish ice hockey first division.

You may not qualify if:

  • Participants taking drugs containing ephedrine or antibiotics.
  • Having suffered a musculoskeletal injury in the 3 months prior to the tests.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidad de Zaragoza

Zaragoza, 50012, Spain

Location

MeSH Terms

Interventions

Caffeine

Intervention Hierarchy (Ancestors)

XanthinesAlkaloidsHeterocyclic CompoundsPurinonesPurinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-Ring

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Participants will be given a bottle with either caffeine and carbohydrates or just carbohydrates.
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Participants will be given a bottle with either caffeine and carbohydrates or just carbohydrates. All participants will complete ice-hockey specific athletic tests in both conditions.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

December 9, 2021

First Posted

December 27, 2021

Study Start

March 1, 2021

Primary Completion

April 30, 2021

Study Completion

May 30, 2021

Last Updated

May 24, 2023

Record last verified: 2023-05

Locations